Elbit Imaging Ltd. Calls 2012 Annual Shareholders Meeting

          Elbit Imaging Ltd. Calls 2012 Annual Shareholders Meeting

PR Newswire

TEL AVIV, Israel, December 10, 2012

TEL AVIV, Israel, December 10, 2012 /PRNewswire/ --

Elbit Imaging Ltd. (NASDAQ: EMITF) (the "Company") announced today that it has
scheduled its 2012 annual shareholders meeting to take place Monday, December
31, 2012 at 11:00 a.m. (Israel time), at the offices of the Company, located
at 2 Weitzman Street, Tel Aviv, Israel. The record date for the meeting is
December 17, 2012.

Proxy statements describing the proposals on the agenda and proxy cards for
use by shareholders that cannot attend the meeting in person will be sent by
mail, on or about December 20, 2012, to the Company's shareholders of record
and to shareholders that hold shares registered with the American Stock
Transfer & Trust Company.The Company will also furnish the proxy statement
to the Securities and Exchange Commission on Form 6-K.

The agenda of the meeting is as follows:

i.To re-elect the following members of the Company's Board of Directors:
   Mordechay Zisser, Shimon Yitzhaki, David Rubner, Moshe Lion and Shmuel
ii.To re-appoint Brightman Almagor Zohar & Co., a member of Deloitte, as the
    Company's independent auditors until the next annual general meeting of
    shareholders; and
iii.To discuss the Company's financial statements for the year ended December
     31, 2011.

Items 1 and 2 require the approval of a simple majority of the shares voted on
the matter.

Item 3 will not require a vote of the shareholders.

About Elbit Imaging Ltd.

Elbit Imaging Ltd. operates in the following principal fields of business: (i)
Commercial and Entertainment Centers - Initiation, construction and sale of
shopping and entertainment centers and other mixed-use real property projects,
predominantly in the retail sector, located in Central and Eastern Europe and
in India; (ii) U.S. Real Property - Investment in commercial real property in
the United States; (iii) Hotels - Hotel operation and management, primarily in
major European cities; (iv) Medical Industries - (a) research and development,
production and marketing of magnetic resonance imaging guided focused
ultrasound treatment equipment and (b) development of stem cell population
expansion technologies and stem cell therapy products for transplantation and
regenerative medicine; (v) Residential Projects - Initiation, construction and
sale of residential projects and other mixed-use real property projects,
predominately residential, located primarily in India and in Eastern Europe;
(vi) Fashion Apparel - Distribution and marketing of fashion apparel and
accessories in Israel; and (vii) OtherActivity - Venture capital investments.

Any forward-looking statements in our releasesinclude statements regarding
the intent, belief or currentexpectations of Elbit Imaging Ltd. and our
management about our business, financial condition, results of operations, and
its relationship with its employees and the condition of our properties. Words
such as"believe," "expect," "intend," "estimate" and similar expressionsare
intended to identify forward-looking statements but are not the exclusive
means of identifying such statements. Actual results may differ materially
from those projected, expressed or implied in the forward-looking statements
as a result of various factors including, without limitation, the factors set
forth in our filings with the Securities and Exchange Commission including,
without limitation, Item 3.D of our annual report on Form 20-F for the fiscal
year ended December 31, 2011, under the caption "Risk Factors". Any
forward-looking statements contained in our releases speak only as of the date
of such release, and we cautionexisting and prospectiveinvestors not to
place undue reliance on such statements. Such forward-looking statements do
not purport to be predictions of future events or circumstances, and
therefore, there can be no assurance that any forward-looking statement
contained our releases will prove to be accurate. We undertake no obligation
to update or revise any forward-looking statements.

For Further Information:

Company Contact:
Shimon Yitzhaki

Chairman of the Board of Directors
Tel: +972-3-608-6048

Investor Contact:
Mor Dagan
Investor Relations
Tel: +972-3-516-7620

SOURCE Elbit Imaging Ltd.
Press spacebar to pause and continue. Press esc to stop.